Scleritis and Episcleritis following Coronavirus Disease (COVID-19) Vaccination-Reference-Cited by-同舟云学术

Scleritis and Episcleritis following Coronavirus Disease (COVID-19) Vaccination

Published:2023-03-08 Issue:6 Volume:31 Page:1184-1190
ISSN:0927-3948
Container-title:Ocular Immunology and Inflammation
language:en
Short-container-title:Ocular Immunology and Inflammation

Author:

Sanjay Srinivasan¹^ORCID,Handa Ashit¹²^ORCID,Kawali Ankush¹^ORCID,Shetty Rohit³^ORCID,Bhakti Mishra Sai¹^ORCID,Mahendradas Padmamalini¹^ORCID

Affiliation:

1. Department of Uveitis and Ocular Immunology, Narayana Nethralaya, Bangalore, India

2. Department of Retina, Narayana Nethralaya, Bangalore, India

3. Department of Neuro-ophthalmology, Cornea and Refractive Surgery, Narayana Nethralaya, Bangalore, India

Funder

autho

Publisher

Informa UK Limited

Subject

Ophthalmology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/09273948.2023.2182324

Reference51 articles.

1. World Health organisation (WHO) https://covid19.who.int/. Accessed on January 8th, 2023.

2. Press Statement by the Drugs Controller General of India (DCGI) on Restricted Emergency approval of COVID-19 virus vaccine. [cited 2021 Nov 23]. Available from: https://www.icmr.gov.in/pdf/press_realease_files/HFW_DCGI_energency_use_authorisation_03012021_2.pdf

3. Serum Institute Of India - ChAdOx1 nCoV- 19 Corona Virus Vaccine (Recombinant) - COVISHIELD. [cited 2021 Nov 23]. Available from: https://www.seruminstitute.com/product_covishield.php

4. COVAXIN - India’s First Indigenous Covid-19 Vaccine | Bharat Biotech. [cited 2021 Nov 23]. Available from: https://www.bharatbiotech.com/covaxin.html

5. India – COVID19 Vaccine Tracker. [cited 2021 December 18th. Available from: https://covid19.trackvaccines.org/country/india/

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on coronavirus disease 2019: Ophthalmic Manifestations and Adverse Reactions to Vaccination;Asia-Pacific Journal of Ophthalmology;2023-11

2. Azd-1222/bbv-152;Reactions Weekly;2023-10-14

3. From the Editors;Ocular Immunology and Inflammation;2023-07-03